Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Clinical utility of miRNA-1, miRNA-29g and miRNA-133s plasma levels in prostate cancer patients with high-intensity training after androgen-deprivation therapy

A. Gazova, A. Samakova, E. Laczo, D. Hamar, M. Polakovicova, M. Jurikova, J. Kyselovic

. 2019 ; 68 (Suppl 2) : S139-S147. [pub] 20191130
. 2019 ; () : S139-S147.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, randomizované kontrolované studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc21028174

The randomized trials showed that the addition of training resistance program to androgen-deprivation therapy (ADT) had many beneficial effects for prostate cancer (PC) patients (significant protective effect on the volume of muscle mass) and the studies have revealed a panel of miRNAs, which are deregulate in PC and may serve as promising biomarkers of PC risk. The primary aim of our present study was to investigate the effect of exercise training to changes in body composition (muscle strength) and the secondary endpoint was to investigate the impact of an exercise training program on plasma levels of selected myogenic microRNAs (miRNAs) (miRNA-1, miRNA-29b, and miRNA-133) in PC patients undergoing the ADT. Effect of ADT and exercise intervention showed significant increase (experimental group vs. control group) the changes in body composition, free testosterone levels, IL-6 and plasma levels of myogenic miRNAs and significant reduced insulin serum levels. In conclusion, resistance training with ADT in the treatment of PC significantly changed the physical and metabolic function and the plasma levels of specific myogenic miRNAs. Our data support with the other publicized results.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc21028174
003      
CZ-PrNML
005      
20220328142849.0
007      
ta
008      
211105s2019 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934298 $2 doi
035    __
$a (PubMed)31842577
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Gažová, Andrea, $d 1980- $7 xx0255822 $u Institute of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Comenius University Bratislava, Slovak Republic
245    10
$a Clinical utility of miRNA-1, miRNA-29g and miRNA-133s plasma levels in prostate cancer patients with high-intensity training after androgen-deprivation therapy / $c A. Gazova, A. Samakova, E. Laczo, D. Hamar, M. Polakovicova, M. Jurikova, J. Kyselovic
504    __
$a Literatura
520    9_
$a The randomized trials showed that the addition of training resistance program to androgen-deprivation therapy (ADT) had many beneficial effects for prostate cancer (PC) patients (significant protective effect on the volume of muscle mass) and the studies have revealed a panel of miRNAs, which are deregulate in PC and may serve as promising biomarkers of PC risk. The primary aim of our present study was to investigate the effect of exercise training to changes in body composition (muscle strength) and the secondary endpoint was to investigate the impact of an exercise training program on plasma levels of selected myogenic microRNAs (miRNAs) (miRNA-1, miRNA-29b, and miRNA-133) in PC patients undergoing the ADT. Effect of ADT and exercise intervention showed significant increase (experimental group vs. control group) the changes in body composition, free testosterone levels, IL-6 and plasma levels of myogenic miRNAs and significant reduced insulin serum levels. In conclusion, resistance training with ADT in the treatment of PC significantly changed the physical and metabolic function and the plasma levels of specific myogenic miRNAs. Our data support with the other publicized results.
650    _2
$a senioři $7 D000368
650    _2
$a antagonisté androgenů $x terapeutické užití $7 D000726
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mikro RNA $x krev $7 D035683
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prospektivní studie $7 D011446
650    _2
$a nádory prostaty $x krev $x terapie $7 D011471
650    12
$a odporový trénink $7 D055070
655    _2
$a časopisecké články $7 D016428
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Samáková, Adriana, $d 1993- $7 xx0267319 $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University Bratislava, Slovak Republic
700    1_
$a Laczo, Eugen, $d 1948- $7 kup19960000054954 $u Faculty of Physical Education and Sports, Comenius University Bratislava, Slovak Republic
700    1_
$a Hamar, Dušan, $d 1952- $7 xx0063163 $u Faculty of Physical Education and Sports, Comenius University Bratislava, Slovak Republic
700    1_
$a Polakovičová, Mája $7 xx0086623 $u Faculty of Physical Education and Sports, Comenius University Bratislava, Slovak Republic $u Faculty of Pharmacy, Comenius University Bratislava, Slovak Republic
700    1_
$a Jurikova, M. $u Institute of Histology and Embryology, Faculty of Medicine, Comenius University Bratislava, Slovak Republic
700    1_
$a Kyselovič, Ján, $d 1963- $7 xx0082943 $u 5th Department of Internal Medicine, Faculty of Medicine, Comenius University Bratislava, University Hospital Bratislava, Slovak Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 68, Suppl 2 (2019), s. S139-S147
773    0_
$t Advances in internal medicine $g (2019), s. S139-S147 $w MED00208905
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31842577 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20211105 $b ABA008
991    __
$a 20220328142847 $b ABA008
999    __
$a ok $b bmc $g 1728776 $s 1148719
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 68 $c Suppl 2 $d S139-S147 $e 20191130 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
BMC    __
$a 2019 $d S139-S147 $m Advances in internal medicine $x MED00208905
LZP    __
$b NLK118 $a Pubmed-20211105

Najít záznam

Citační ukazatele

Možnosti archivace